Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Necitumumab PK with Gemcitabine-Cisplatin in Advanced Solid Tumors
NCT01606748Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2012
- Primary completion
- Jun 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of necitumumab in solid tumor (advanced stage), sponsored by Eli Lilly and Company. Started Aug 2012; status: completed.
02
Drugs
necitumumab
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT01606748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606748.